Back to Results
First PageMeta Content
Pediatrics / Pfizer / Growth hormone treatment / Food and Drug Administration / Pharmaceutical industry / Growth hormone deficiency / Growth hormone / Pharmacia / Clinical trial / Medicine / Health / Growth hormones


Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Genotropin
Add to Reading List

Document Date: 2013-01-24 11:50:47


Open Document

File Size: 731,68 KB

Share Result on Facebook

Company

AEs / Pharmacia / H01AC01 Pharmaceutical / Pfizer Ltd / /

Country

Denmark / /

Event

FDA Phase / /

Facility

Genotropin INN / /

IndustryTerm

pharmaceutical formulation / growth hormone injection devices / medicinal product / medicinal products / pen delivery systems / /

MedicalCondition

Turner syndrome / pronounced growth hormone deficiency / TB / Disease / Headache / nasopharyngitis / severe growth hormone deficiency / muscle spasms / chronic renal insufficiency / heart disease / injection site injury / diabetes / minor illness / nephrotic syndrome / Prader-Willi syndrome / pain / growth hormone deficiency / juvenile idiopathic arthritis / laryngitis / diarrhea / deficiency / pituitary/hypothalamic disease / chronic systemic disorders / /

MedicalTreatment

hormone treatment / /

Organization

European Union / European Parliament / /

Position

investigator / principal investigator / EXECUTIVE / /

Product

HP iPAQ Headphone/Headset / Genotropin / /

ProvinceOrState

South Dakota / /

Technology

recombinant DNA / /

SocialTag